An international team of investigators conducted a multicenter, prospective, observational study to identify factors contributing to acute decompensation of cirrhosis.
The USPSTF concludes that screening adults and adolescents at increased risk for hepatitis B virus infection has moderate net benefit.
The national organ shortage has led researchers to criticallyre-evaluate organ sources that previously were considered toorisky for HIV patients.
Researchers assessed the contemporary epidemiology of liver-related complications in women and projected cirrhosis disease burden to 2040.
Based on guidelines issued by the World Health Organizations in 2018, the American College of Physicians has issued best practice advice that simplifies and improves treatment of chronic hepatitis C virus.
Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.
In a Society for Healthcare Epidemiology of America white paper, updated recommendations are presented for health care personnel living with hepatitis and HIV.
Researchers conducted a retrospective cohort study to analyze national trends in drug payments and other associated costs of HIV PrEP treatment.
Acute pancreatitis may be a gastrointestinal manifestation of COVID-19, according to researchers from the University of Arkansas for Medical Sciences.
A team of investigators sought to investigate the rate of resolution of Clostridioides difficile infection as well as safety associated with fecal microbiota transplantation in patients with liver cirrhosis.
The CDC presented recommendations for testing and clinical management of health care personnel exposed to the hepatitis C virus.
Researchers found that no patients with concomitant COVID-19 and hepatitis B virus infection progressed to severe or critically ill status during hospitalization, but many had abnormal liver function tests on admission.
A viral exposure signature can predict hepatocellular carcinoma risk before clinical diagnosis among at-risk patients.
Hepatitis C screening is recommended for all adults and for all pregnant women, except where the prevalence is below 0.1%.
Causes of Budd-Chiari syndrome include myeloproliferative syndromes, malignancy, infection, and Behҫet syndrome.
B recommendation applies to all asymptomatic adults ages 18 to 79 years regardless of risk.
Administration of simeprevir is more problematic with ART; sofosbuvir has fewest interactions with ART.
In women with HIV, lower education and hepatitis C co-infection are independently associated with the onset of menopause before age 45 years.
Sustained virologic response rates similar for patients 65 years and older, patients younger than 65 years.
Airline is working with the CDC to coordinate ‘any required health and safety related measures’.